1. Warren JR, Marshall B. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet. 1983; 1:1273–1275.
2. Infection with Helicobacter pylori. IARC Monogr Eval Carcinog Risks Hum. 1994; 61:177–240.
3. Kamada T, Haruma K, Ito M, et al. Time trends in Helicobacter pylori infection and atrophic gastritis over 40 years in Japan. Helicobacter. 2015; 20:192–198.
4. Ono S, Kato M, Suzuki M, et al. Frequency of Helicobacter pylori -negative gastric cancer and gastric mucosal atrophy in a Japanese endoscopic submucosal dissection series including histological, endoscopic and serological atrophy. Digestion. 2012; 86:59–65.
Article
5. Kim HJ, Kim N, Yoon H, et al. Comparison between resectable Helicobacter pylori-negative and -positive gastric cancers. Gut Liver. 2016; 10:212–219.
Article
6. Yamada A, Kaise M, Inoshita N, et al. Characterization of Helicobacter pylori-naïve early gastric cancers. Digestion. 2018; 98:127–134.
Article
7. Sato C, Hirasawa K, Tateishi Y, et al. Clinicopathological features of early gastric cancers arising in Helicobacter pylori uninfected patients. World J Gastroenterol. 2020; 26:2618–2631.
Article
8. Akazawa Y, Ueyama H, Hayashi T, et al. Clinicopathological and molecular characterization of early gastric adenocarcinoma in Helicobacter pylori-uninfected patients: emphasis on differentiated gastric adenocarcinoma. J Gastroenterol. 2022; 57:725–734.
Article
9. Kimura K, Takemoto T. An endoscopic recognition of the atrophic border and its significance in chronic gastritis. Endoscopy. 1969; 1:87–97.
Article
10. Sakaki N, Momma K, Egawa N, et al. The influence of Helicobacter pylori infection on the progression of gastric mucosal atrophy and occurrence of gastric cancer. Eur J Gastroenterol Hepatol. 1995; 7 Suppl 1:S59–S62.
11. Yao K. The endoscopic diagnosis of early gastric cancer. Ann Gastroenterol. 2013; 26:11–22.
12. Yao K, Anagnostopoulos GK, Ragunath K. Magnifying endoscopy for diagnosing and delineating early gastric cancer. Endoscopy. 2009; 41:462–467.
Article
13. Yoon H, Kim N, Lee HS, et al. Helicobacter pylori-negative gastric cancer in South Korea: incidence and clinicopathologic characteristics. Helicobacter. 2011; 16:382–388.
Article
14. Okano A, Kato S, Ohana M. Helicobacter pylori-negative gastric cancer: advanced-stage undifferentiated adenocarcinoma located in the pyloric gland area. Clin J Gastroenterol. 2017; 10:13–17.
Article
15. Hayashi J, Yamatsuji T, Suehiro M, et al. Helicobacter pylori-negative advanced gastric cancer arising from the gastric mucosa without inflammation, atrophy, or intestinal metaplasia. Case Rep Gastroenterol. 2022; 16:345–350.
Article
16. Takagi A, Ozawa H, Oki M, et al. Helicobacter pylori-negative advanced gastric cancer with massive eosinophilia. Intern Med. 2018; 57:1715–1718.
Article
17. Ueyama H, Yao T, Nakashima Y, et al. Gastric adenocarcinoma of fundic gland type (chief cell predominant type): proposal for a new entity of gastric adenocarcinoma. Am J Surg Pathol. 2010; 34:609–619.
Article
18. Ueyama H, Yao T, Akazawa Y, et al. Gastric epithelial neoplasm of fundic-gland mucosa lineage: proposal for a new classification in association with gastric adenocarcinoma of fundic-gland type. J Gastroenterol. 2021; 56:814–828.
Article
19. Imamura K, Yao K, Nimura S, et al. Characteristic endoscopic findings of gastric adenocarcinoma of fundic-gland mucosa type. Gastric Cancer. 2021; 24:1307–1319.
Article
20. Kanesaka T, Uedo N, Yao K, et al. New subtype of gastric adenocarcinoma: mixed fundic and pyloric mucosa-type adenocarcinoma. Clin J Gastroenterol. 2017; 10:224–228.
Article
21. Takahashi H, Yao K, Ueo T, et al. Histological subtype of gastric adenocarcinoma: two cases of mixed fundic and pyloric mucosa-type adenocarcinoma. Ecancermedicalscience. 2020; 14:1143.
Article
22. Shibagaki K, Fukuyama C, Mikami H, et al. Gastric foveolar-type adenomas endoscopically showing a raspberry-like appearance in the Helicobacter pylori-uninfected stomach. Endosc Int Open. 2019; 7:E784–E791.
Article
23. Arai J, Niikura R, Hayakawa Y, et al. Clinicopathological features of gastric cancer with autoimmune gastritis. Biomedicines. 2022; 10:884.
Article
24. Nikaido M, Kakiuchi N, Miyamoto S, et al. Indolent feature of Helicobacter pylori-uninfected intramucosal signet ring cell carcinomas with CDH1 mutations. Gastric Cancer. 2021; 24:1102–1114.
Article
25. Muraishi J, Miyaoka M, Imamura K, et al. A case of gastric signet-ring cell carcinoma with a long-term retrospective follow-up of 17 years. Clin J Gastroenterol. 2021; 14:1337–1343.
Article
26. Takita M, Ohata K, Inamoto R, et al. Endoscopic and histological features of Helicobacter pylori-negative differentiated gastric adenocarcinoma arising in the antrum. JGH Open. 2021; 5:470–477.
Article
27. Kushima R, Nimura S. Stomach. In : Fukayama M, Morinaga S, editors. Surgical pathology. 5th ed. Bunkodo;2020. p. 444–515.
28. Matsuhisa T, Tsukui T. Relation between reflux of bile acids into the stomach and gastric mucosal atrophy, intestinal metaplasia in biopsy specimens. J Clin Biochem Nutr. 2012; 50:217–221.
Article
29. Tatsugami M, Ito M, Tanaka S, et al. Bile acid promotes intestinal metaplasia and gastric carcinogenesis. Cancer Epidemiol Biomarkers Prev. 2012; 21:2101–2107.
Article
30. Matsuhisa T, Arakawa T, Watanabe T, et al. Relation between bile acid reflux into the stomach and the risk of atrophic gastritis and intestinal metaplasia: a multicenter study of 2283 cases. Dig Endosc. 2013; 25:519–525.
Article
31. Li D, Zhang J, Yao WZ, et al. The relationship between gastric cancer, its precancerous lesions and bile reflux: a retrospective study. J Dig Dis. 2020; 21:222–229.
Article